查看購物車
  • English
  • Japanese
  • Korean
本報告分析了醫療保健領域人工智慧市場的規模和預測（2021-2034 年），包括全球和區域市場佔有率、趨勢和成長機會，並按組件、部署模式、組織規模和地區進行了細分。
市場調查報告書
商品編碼
1997084

本報告分析了醫療保健領域人工智慧市場的規模和預測（2021-2034 年），包括全球和區域市場佔有率、趨勢和成長機會，並按組件、部署模式、組織規模和地區進行了細分。

AI in Healthcare Market Size and Forecast 2021 - 2034, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Component, Deployment, Organization Size, and Geography
出版日期: | 出版商: The Insight Partners | 英文 234 Pages | 訂單完成後即時交付

價格
2025年，醫療領域的人工智慧市場價值為395.5億美元，預計到2034年將達到1.07842兆美元。醫療領域的人工智慧市場預計從2026年到2034年將達到45.3%的複合年成長率。

現代醫療保健系統透過電子健康記錄 (EHR)、醫學影像系統、穿戴式裝置、遠端監測工具和連線健診平台產生大量資料。人工智慧使醫療服務提供者能夠分析這些數據，從而實現預測性診斷、即時病患監測、人群健康管理、最佳化治療和個人化護理。患者對遠距醫療、虛擬助理、遠端患者監護監測和自動化預約管理等數位健康服務的需求日益成長，正在加速人工智慧的普及應用。

醫療服務提供者和生命科學公司正在利用人工智慧來改善病人參與、最佳化臨床結果並降低營運成本。人工智慧與雲端運算和邊緣運算的融合，增強了重症監護環境中的可擴展性、數據存取能力和響應速度。監管機構對數位化醫療轉型和可互通醫療基礎設施的支持也促進了市場成長。此外，醫療機構、科技公司和研究機構之間的夥伴關係正在加強人工智慧驅動的醫療解決方案。

2026年1月，Digital.ai宣布推出業界首個針對醫療保健領域行動和Web應用程式的端到端自動化測試支持，進一步擴展了連線健診平台上的數位化測試能力。該公司協助企業團隊實現關鍵臨床和病患工作流程的自動化，擴大測試覆蓋範圍，並在真實環境中大規模檢驗效能，而無需依賴複雜的實體環境或分散的系統。

隨著醫療服務模式從孤立的臨床環境向一體化的數位生態系統轉變，人工智慧驅動的分析、自動化和個人化變得至關重要。這種向數據主導醫療環境的轉變，持續推動人工智慧在各個領域的應用，涵蓋醫療服務、臨床研究、醫院運作以及術後病患照護等各個層面。

北美地區擁有強大的技術基礎設施，在醫療資訊科技領域投入龐大，並率先採用先進的數位醫療解決方案。該地區，尤其是美國，匯聚了許多領先的醫療服務提供者、製藥公司、醫療設備製造商和人工智慧技術公司。人工智慧應用已深度融入醫學影像分析、預測診斷、臨床決策支援系統、醫院工作流程自動化和人群健康管理解決方案等領域。

旨在提升病患安全、資料互通性和推廣以價值為導向的醫療模式的監管舉措，正在進一步加速人工智慧的整合。美國憑藉有利的法規結構和舉措支持，在數位醫療創新領域處於主導地位。此外，遠端醫療和遠端患者監護的日益普及，也推動了對人工智慧驅動的數據分析、風險分層和個人化治療方案的需求。

患者對便利性、個人化和高品質醫療保健的需求持續推動市場成長。在北美，強大的創業投資以及醫療機構與科技公司之間的策略合作也為市場發展提供了助力，加速了人工智慧解決方案的商業化進程。然而，資料隱私法規、網路安全風險、倫理考量以及高昂的實施成本等挑戰依然存在。總體而言，在持續創新、強大的生態系統以及新一代醫療技術的高普及率的推動下，北美有望繼續保持主導地位。

人工智慧在最佳化臨床工作流程、資源分配、診斷準確性和治療方案製定方面發揮著至關重要的作用。醫療機構正日益利用人工智慧來增強疾病預測、病患風險評估和最佳化診療路徑。隨著人口老化和慢性病的盛行率上升，全球對高效、以結果為導向的醫療服務的需求不斷成長，醫療服務提供者正投資於人工智慧工具，以提高醫療品質並降低營運成本。人工智慧還支援醫療設備的預測性維護和效能監測，從而實現主動維護並提高設備可靠性。

此外，人工智慧驅動的類比數位雙胞胎技術能夠加速藥物發現、臨床試驗設計和醫療設備開發流程。將人工智慧與交換醫療資訊系統和互聯醫療網路相整合，可進一步增強資料互通性和醫療協調性。世界各國政府正透過資助計畫和基礎設施投資支持數位醫療的普及，為人工智慧的整合創造了有利條件。在醫療市場競爭日益激烈的背景下，採用人工智慧驅動的最佳化策略的機構正在獲得競爭優勢。因此，不斷發展的數位醫療生態系統為人工智慧解決方案在臨床營運、藥物研發、醫療設備製造和醫療數據管理應用領域提供了長期發展機會。

目錄

第1章：執行摘要

  • 分析師市場展望
  • 市場吸引力

第2章：人工智慧在醫療領域的市場現狀

  • 價值鏈分析
    • 原料和零件
    • 醫療流程/技術
    • 流通結構
    • 最終用戶
    • 整合程度
  • 供應鏈分析
    • 製造商/供應商列表
    • 潛在客戶名單（最多 50 家公司）
  • 波特五力分析
  • PEST分析
  • 人工智慧（AI）的影響
  • 法律規範

第3章 競爭情勢

  • 主要企業進行標竿分析
  • 市佔率分析（2025 年）－按主要企業分類
  • 市場集中度

第4章：醫療領域的人工智慧市場－關鍵市場動態

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 未來趨勢
  • 促進因素和抑制因素的影響

第5章：人工智慧在醫療領域的市場－全球市場分析

  • 2021-2034年醫療領域人工智慧市場收入
  • 醫療領域人工智慧市場預測與分析

第6章：醫療領域人工智慧市場收入分析－按組件分類

  • 基於組件的醫療領域人工智慧市場預測與分析
  • 硬體
    • 硬體市場收入，2021-2034年
  • 軟體
    • 軟體市場收入（2021-2034 年）
  • 服務
    • 2021-2034年服務市場收入

第7章：人工智慧在醫療領域的市場收入分析－實施模式

  • 依實施方法對醫療領域人工智慧市場應用進行預測與分析。
  • 雲
    • 2021-2034年雲端運算市場收入
  • 現場
    • 2021-2034年現場消費市場收入

第8章：醫療保健產業人工智慧市場收入分析－按機構規模分類

  • 按組織規模分類的醫療保健產業人工智慧市場預測與分析
  • 主要企業
    • 2021-2034年大型企業市場收入
  • 小型企業
    • 2021-2034年中小企業市場收益

第9章：人工智慧在醫療領域的市場－區域分析

  • 北美洲
    • 成分
    • 實作方法
    • 組織規模
    • 美國市場
    • 加拿大市場
    • 墨西哥市場
  • 歐洲
    • 德國
    • 法國
    • 義大利
    • 英國
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 澳洲
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東和非洲地區
  • 中美洲和南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區以及中南美洲

第10章：醫療領域人工智慧市場的產業趨勢

第11章：醫療保健領域的人工智慧市場—主要企業概況

  • Accenture Plc
  • Advanced Micro Devices Inc
  • Google LLC
  • International Business Machines Corp
  • Intel Corp
  • Microsoft Corp
  • NVIDIA Corp
  • Amazon Web Services Inc
  • SAP SE
  • SAS Institute Inc

第12章：分析中包含的其他公司列表

第13章附錄

Product Code: TIPRE00042231

The AI in Healthcare Market size was valued at US$ 39.55 billion in 2025 and is expected to reach US$1078.42 billion by 2034. The AI in healthcare market is estimated to register a CAGR of 45.3% during 2026-2034.

Modern healthcare systems generate vast amounts of data through electronic health records (EHRs), medical imaging systems, wearable devices, remote monitoring tools, and connected health platforms. AI enables healthcare providers to analyze this data for predictive diagnostics, real-time patient monitoring, population health management, treatment optimization, and personalized care delivery. Increasing patient demand for digital health services such as teleconsultations, virtual assistants, remote patient monitoring, and automated appointment management is accelerating AI adoption.

Healthcare providers and life sciences organizations are leveraging AI to enhance patient engagement, optimize clinical outcomes, and reduce operational costs. Integration of AI with cloud computing and edge processing improves scalability, data accessibility, and response times in critical care settings. Regulatory support for digital health transformation and interoperable healthcare infrastructure also contributes to market growth. Additionally, partnerships between healthcare institutions, technology companies, and research organizations are strengthening AI-enabled healthcare solutions.

In January 2026, Digital.ai announced industry-first support for end-to-end automated testing of healthcare mobile and web applications, expanding its digital testing capabilities across connected health platforms. The company enables enterprise teams to automate critical clinical and patient-facing workflows, expand test coverage, and validate real-world performance at scale without relying on complex physical environments or fragmented systems.

As healthcare delivery increasingly functions as an integrated digital ecosystem rather than isolated clinical settings, AI-driven analytics, automation, and personalization are becoming essential. This shift toward data-driven healthcare environments continues to propel AI adoption across care delivery, clinical research, hospital operations, and post-treatment patient management.

North America has a strong technological infrastructure, high healthcare IT investments, and early adoption of advanced digital health solutions. The region is characterized by the presence of leading healthcare providers, pharmaceutical companies, medical device manufacturers, and AI technology firms, particularly in the US. AI applications are deeply embedded across medical imaging analysis, predictive diagnostics, clinical decision support systems, hospital workflow automation, and population health management solutions.

Regulatory initiatives promoting patient safety, data interoperability, and value-based care models have further accelerated AI integration. The US leads in digital health innovation programs, supported by favorable regulatory frameworks and funding initiatives. Additionally, the growing adoption of telehealth and remote patient monitoring has increased demand for AI-enabled data analytics, risk stratification, and personalized treatment planning.

Patient demand for accessible, personalized, and high-quality care continues to fuel market growth. North America also benefits from strong venture capital funding and strategic partnerships between healthcare organizations and technology firms, driving rapid commercialization of AI solutions. However, challenges remain in the form of data privacy regulations, cybersecurity risks, ethical considerations, and high implementation costs. Overall, North America is expected to maintain a leading position in the market, driven by continuous innovation, strong ecosystem collaboration, and high adoption of next-generation healthcare technologies.

AI plays a critical role in optimizing clinical workflows, resource allocation, diagnostic accuracy, and treatment planning. Healthcare organizations are increasingly leveraging AI to enhance disease prediction, patient risk assessment, and care pathway optimization. As global demand for efficient and outcome-based healthcare services rises due to aging populations and chronic disease prevalence, providers are investing in AI-driven tools to improve care quality and reduce operational expenses. AI also supports predictive maintenance and performance monitoring of medical equipment, enabling proactive servicing and improved reliability.

Additionally, AI-driven simulation and digital twin technologies accelerate drug discovery, clinical trial design, and medical device development processes. Integration of AI with health information exchanges and connected care networks further enhances data interoperability and care coordination. Governments worldwide are supporting digital health adoption through funding programs and infrastructure investments, creating favorable conditions for AI integration. As competition intensifies in the healthcare market, organizations adopting AI-driven optimization strategies gain a competitive advantage. Thus, an expanding digital health ecosystem creates long-term opportunities for AI solutions across clinical operations, pharmaceutical research, medical device manufacturing, and healthcare data management applications.

Accenture Plc, Advanced Micro Devices Inc, Google LLC, International Business Machines Corp, Intel Corp, Microsoft Corp, NVIDIA Corp, Amazon Web Services Inc, SAP SE, and SAS Institute Inc are among the key AI in healthcare market players that are profiled in this market study.

The overall AI in healthcare market size has been derived using both primary and secondary sources. Exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the AI in healthcare market size. The process also helps obtain an overview and forecast of the market with respect to all the market segments. Also, multiple primary interviews have been conducted with industry participants to validate the data and gain analytical insights. This process includes industry experts such as VPs, business development managers, market intelligence managers, and national sales managers, along with external consultants such as valuation experts, research analysts, and key opinion leaders, specializing in the AI in healthcare market.

Table Of Contents

1. Executive Summary

  • 1.1 Analyst Market Outlook
  • 1.2 Market Attractiveness

2. AI in Healthcare Market Landscape

  • 2.1 Overview
  • 2.2 Value Chain Analysis
    • 2.2.1 Raw Materials/Components
    • 2.2.2 Healthcare Process/Technology
    • 2.2.3 Distribution Landscape
    • 2.2.4 End-User
    • 2.2.5 Level of Integration
  • 2.3 Supply Chain Analysis
    • 2.3.1 List of Manufacturers/Suppliers
    • 2.3.2 List of Potential Customers (Upto 50)
  • 2.4 Porter's Five Force Analysis
  • 2.5 PEST Analysis
  • 2.6 Impact of Artificial Intelligence (AI)
  • 2.7 Regulatory Framework

3. Competitive Landscape

  • 3.1 Company Benchmarking by Key Players
  • 3.2 Market Share Analysis, 2025 - By Key Players
  • 3.3 Market Concentration

4. AI in Healthcare Market - Key Industry Dynamics

  • 4.1 Market Drivers
  • 4.2 Market Restraints
  • 4.3 Market Opportunities
  • 4.4 Future Trends
  • 4.5 Impact of Drivers and Restraints

5. AI in Healthcare Market - Global Market Analysis

  • 5.1 AI in Healthcare Market Revenue (US$ Million), 2021-2034
  • 5.2 AI in Healthcare Market Forecast and Analysis

6. AI in Healthcare Market Revenue Analysis - Component

  • 6.1 AI in Healthcare Market Forecasts and Analysis by Component
  • 6.2 Hardware
    • 6.2.1 Overview
    • 6.2.2 Hardware Market Revenue, 2021-2034 (US$ Million)
  • 6.3 Software
    • 6.3.1 Overview
    • 6.3.2 Software Market Revenue, 2021-2034 (US$ Million)
  • 6.4 Services
    • 6.4.1 Overview
    • 6.4.2 Services Market Revenue, 2021-2034 (US$ Million)

7. AI in Healthcare Market Revenue Analysis - Deployment

  • 7.1 AI in Healthcare Market Forecasts and Analysis by Deployment
  • 7.2 Cloud
    • 7.2.1 Overview
    • 7.2.2 Cloud Market Revenue, 2021-2034 (US$ Million)
  • 7.3 On-Premises
    • 7.3.1 Overview
    • 7.3.2 On-Premises Market Revenue, 2021-2034 (US$ Million)

8. AI in Healthcare Market Revenue Analysis - Organization Size

  • 8.1 AI in Healthcare Market Forecasts and Analysis by Organization Size
  • 8.2 Large Enterprises
    • 8.2.1 Overview
    • 8.2.2 Large Enterprises Market Revenue, 2021-2034 (US$ Million)
  • 8.3 SMEs
    • 8.3.1 Overview
    • 8.3.2 SMEs Market Revenue, 2021-2034 (US$ Million)

9. AI in Healthcare Market - Geographical Analysis

  • 9.1 North America
    • 9.1.1 North America AI in Healthcare Market Overview
    • 9.1.2 North America: AI in Healthcare Market Revenue and Forecasts, 2021-2034 (US$ Million)
    • 9.1.3 North America: AI in Healthcare Market - By Segmentation
      • 9.1.3.1 Component
      • 9.1.3.2 Deployment
      • 9.1.3.3 Organization Size
    • 9.1.4 North America: AI in Healthcare Market Breakdown by Countries
      • 9.1.4.1 United States Market
        • 9.1.4.1.1 United States: AI in Healthcare Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.1.4.1.2 United States: AI in Healthcare Market - By Segmentation
          • 9.1.4.1.2.1 Component
          • 9.1.4.1.2.2 Deployment
          • 9.1.4.1.2.3 Organization Size
      • 9.1.4.2 Canada Market
      • 9.1.4.3 Mexico Market
  • 9.2 Europe
    • 9.2.1 Germany
    • 9.2.2 France
    • 9.2.3 Italy
    • 9.2.4 United Kingdom
    • 9.2.5 Russia
    • 9.2.6 Rest of Europe
  • 9.3 Asia-Pacific
    • 9.3.1 Australia
    • 9.3.2 China
    • 9.3.3 India
    • 9.3.4 Japan
    • 9.3.5 South Korea
    • 9.3.6 Rest of Asia-Pacific
  • 9.4 Middle East and Africa
    • 9.4.1 South Africa
    • 9.4.2 Saudi Arabia
    • 9.4.3 U.A.E
    • 9.4.4 Rest of Middle East and Africa
  • 9.5 South and Central America
    • 9.5.1 Brazil
    • 9.5.2 Argentina
    • 9.5.3 Rest of South and Central America

10. AI in Healthcare Market Industry Landscape

11. AI in Healthcare Market - Key Company Profiles

  • 11.1 Accenture Plc
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Advanced Micro Devices Inc
  • 11.3 Google LLC
  • 11.4 International Business Machines Corp
  • 11.5 Intel Corp
  • 11.6 Microsoft Corp
  • 11.7 NVIDIA Corp
  • 11.8 Amazon Web Services Inc
  • 11.9 SAP SE
  • 11.10 SAS Institute Inc

12. List of Additional Companies Analyzed

13. Appendix

  • 13.1 Glossary
  • 13.4 Research Methodology and Approach
    • 13.4.1 Secondary Research
    • 13.4.2 Primary Research
    • 13.4.3 Market Estimation Approach
      • 13.4.3.1 Supply Side Analysis
      • 13.4.3.2 Demand Side Analysis
    • 13.4.4 Research Assumptions and Limitations
  • 13.5 Meet Our Analysts
  • 13.6 About The Insight Partners
  • 13.7 Market Intelligence Cloud

List Of Figures

  • Table 1. List of Regulatory Bodies and Organizations
  • Table 2. AI in Healthcare Market Revenue, 2021-2025 (US$ Million)
  • Table 3. AI in Healthcare Market Revenue, 2026-2034 (US$ Million)
  • Table 4. North America AI in Healthcare Market Revenue, 2021-2025 (US$ Million) - Component
  • Table 5. North America AI in Healthcare Market Revenue and Forecasts, 2026-2034 (US$ Million) - Component
  • Table 6. North America AI in Healthcare Market Revenue, 2021-2025 (US$ Million) - Deployment
  • Table 7. North America AI in Healthcare Market Revenue and Forecasts, 2026-2034 (US$ Million) - Deployment
  • Table 8. North America AI in Healthcare Market Revenue, 2021-2025 (US$ Million) - Organization Size
  • Table 9. North America AI in Healthcare Market Revenue and Forecasts, 2026-2034 (US$ Million) - Organization Size
  • Table 10. United States: AI in Healthcare Market Revenue, 2021-2025 (US$ Million) - Component
  • Table 11. United States: AI in Healthcare Market Revenue and Forecasts, 2026-2034 (US$ Million) - Component
  • Table 12. United States: AI in Healthcare Market Revenue, 2021-2025 (US$ Million) - Deployment
  • Table 13. United States: AI in Healthcare Market Revenue and Forecasts, 2026-2034 (US$ Million) - Deployment
  • Table 14. United States: AI in Healthcare Market Revenue, 2021-2025 (US$ Million) - Organization Size
  • Table 15. United States: AI in Healthcare Market Revenue and Forecasts, 2026-2034 (US$ Million) - Organization Size
  • Table 16. List of Additional Companies Analyzed
  • Table 17. Glossary - AI in Healthcare Market